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ABSTRACT: This study describes the epidemiological, clinical, and mi-
crobiological characteristics of a new tick-borne disease in Spain—
Dermacentor-borne necrosis erythema lymphadenopathy (DEBONEL).
The clinical presentations include an eschar at the site of the tick bite,
surrounded by an erythema and painful regional lymphadenopathy. The
disease appears during the colder months and its vector is Dermacentor
marginatus (D. marginatus). From January 1990 to December 2004, 54
patients presented at Hospital of La Rioja with these clinical and epi-
demiological data. The ratio of females to males was 32/22. The average
age was 37 years. In all cases tick bites were located on the upper body
(90% on the scalp). The median incubation period was 4.7 days. Signs and
symptoms were mild in all cases. Only a small number of patients pre-
sented mild and nonspecific abnormalities in a complete blood cell count
and mild elevation of erythrocyte sedimentation rates and C-protein
reactive and liver enzyme levels. Serological evidence of acute rickettsio-
sis was observed in 19 patients (61%). In 29% sera tested by polymerase
chain reactions (PCRs) were positive. The sequence obtained from a PCR
product revealed 98% identity with Rickettsia sp. strains RpA4, DnS14,
and DnS28. All ticks removed from patients were PCR-positive. Sequenc-
ing showed 8 of them identified as R. slovaca and 2 as Rickettsia sp. strains
RpA4, DnS14, and DnS28.
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INTRODUCTION
Ticks have been described as vectors of human infectious diseases since the
beginning of the 20th century. In the last few years, different emerging tick-
borne diseases (TBDs) have been reported all over the world. The development
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of new techniques, including the shell vial assay for isolation of organisms and
molecular methods for their characterization, has allowed the etiology of many
of these diseases to be known.1
Since 1990, we have investigated TBDs in the Hospital of La Rioja. Lyme
borreliosis (LB) and Mediterranean spotted fever (MSF) are the most prevalent
TBDs in our area, although some cases of human anaplasmosis have been
described.2
In November 1996 a 67-year-old man was evaluated for eschar on the tho-
racic region surrounded by an erythema (erythema migrans–like) after a tick
bite. On examination he had several painful points of axillary lymphadenopa-
thy. He kept the tick, which was identified as a female adult Dermacentor
marginatus (D. marginatus). At this time, D. marginatus was only implicated
as a vector of one case of LB.3 No antibodies against Borrelia burgdorferi,
Rickettsia conorii, Anaplasma phagocytophilum, or Francisella tularensis were
found. A skin biopsy was performed in order to investigate the presence of B.
burgdorferi by polymerase chain reaction (PCR) and isolation in BSK medium,
but without success. The PCR from the tick was also negative for B. burgdor-
feri. The patient was treated with doxycycline and signs and symptoms were
soon alleviated. R. slovaca was identified by PCR from the frozen tick few
years later.4 Since the description of this case, we revised all TBDs seen at
our hospital up to that moment. In addition, we began to collect data and in
same cases sera specimens from patients who presented with similar clinical
findings.
MATERIALS AND METHODS
Patients
Patients’ inclusion criteria were: (1) a crusted lesion or a point of necrosis
(eschar) at the site of the tick attachment, surrounded by erythema and painful
regional lymphadenopathy; and (2) tick bite by D. marginatus or a large tick
during the period of maximum activity for D. marginatus (in our area from the
end of October to the beginning of May).
The study was retrospective from January 1990 to December 2000 and
prospective from January 2001 to December 2004.
Epidemiological and clinical data were obtained for patients studied prospec-
tively. They were asked about the underlying diseases, date and site of the tick
bite, method of removing the tick, geographical location and clinical features,
evolution, and treatment. Routine laboratory tests (complete blood cell count,
erythrocyte sedimentation rates, ASAT and ALAT, and C reactive protein) were
performed. All these patients were reexamined 1, 4, 12, and 24 weeks after the
initial visit. For the patients studied retrospectively these data were collected
(when were available) from the clinical histories.
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Patients diagnosed with erythema migrans (LB) and MSF during 2003–2004
were used as controls.
Ticks
D. marginatus was collected from people: 10 from patients and 4 from
asymptomatic persons.
Microbiological Tests
From 31 patients an acute-phase serum (before starting the treatment) and
late-phase sera samples (1st, 3rd, and 6th months) were taken. From 21 patients
an EDTA-blood sample was obtained. In eight cases skin biopsy specimens of
the border of the lesion were also obtained. All samples were centrifuged and
frozen at −70◦ C until examination. All D. marginatus collected from people
were classified with regard to genus and species and kept in 70% alcohol before
being processed.
Serological Tests
Acute and convalescent sera samples were tested by an indirect immunoflu-
orescence assay (IFA) for the presence of IgG antibodies against R. conorii
(BioMe´rieux, Lyon, France) and Rickettsia slovaca (antigen slides kindly do-
nated by Dr. Fa´tima Bacellar, Centro de Estudos de Vectores e Doenc¸as Infec-
ciosas do Instituto Nacional de Sau´de, Portugal). Seroconversion, or a fourfold
increase in the sera obtained in the late phase, was considered evidence of re-
cent infection by spotted fever group (SFG) Rickettsia.
Molecular Methods
The acute-phase sera, the EDTA blood samples, the skin biopsy samples, as
well as all D. marginatus specimens removed from people were analyzed by
PCR assays.
DNA was extracted using the QIAamp Tissue kit (Qiagen, Hilden, Germany)
according to the manufacturer’ recommendations. The presence of SFG Rick-
ettsia in human samples was determined by PCR assays for ompA5 and gltA6
genes. All ticks were also screened for the presence of B. burgdorferi, A. phago-
cytophilum, and F. tularensis by the partial amplification of the 16S rDNA,
msp2, and 17-kDa lipoprotein genes, respectively. Sequencing reactions were
carried out at Universidad de Alcala´ de Henares (Spain). Sequences obtained
were compared with those available at Genbank using BLAST utility (National
Center for Biotechnology Information <http://www.ncbi.nlm.nih.gov>).
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RESULTS
Epidemiological and Clinical Data
From January 1990 to December 2004, 54 patients who presented at our
hospital with TBDs had the inclusion criteria for the study. The study was
retrospective for 20 patients and prospective for 34 patients. Thirty-two pa-
tients (59%) were female and 22 (41%) were male. The median age was 37
years (range 3–78). All patients were bitten during the colder months (from
the end of October to the beginning of May), with a peak in November (12
cases) and April (10 cases). No was observed from June to September. All
patients remembered that they had been bitten by a “very large” tick. Forty-
seven patients (87%) removed the tick by hand, nearly always after previous
administration of oil on the site of the tick attachment. Three of them kept
the ticks. Seven patients were seen with the tick attached, which was removed
by forceps. In all 10 cases the tick was identified as D. marginatus. All pa-
tients gave information about the geographical area where the tick had bitten
them (96% in La Rioja Baja). The incubation period varied from 1 to 13 days
(median 4.7). In 48 patients (90%) the tick bite was located on the scalp,
while 3 patients were bitten on the arms and 2 on the thorax. In all cases,
the tick bite was located on the upper portions of the body. The typical skin
lesion at the site of the tick bite started as a crusted lesion. A necrotic es-
char (0.5 to 2.5 cm in diameter), surrounded by erythema, appeared a few
days later. In eight cases (15%) the erythema was higher than 5 cm (erythema
migrans-like). In all patients whose tick bites were located on the scalp region,
erythema was higher than 5 cm in diameter (33 cm in one patient). Multi-
ple and painful regional lymphadenopathy was the other major feature, being
present in all cases. Only four patients presented with the skin lesion few days
before the onset of lymphadenopathy. Most patients with the skin lesion on the
scalp region suffered from headache. Low-grade fever (<38◦C) was observed
in 18 patients (33%), and 2 patients (3.7%) had fever higher than 38.5◦C.
A macular rash, which did not affect either palms or soles, was observed in
only one patient. Routine laboratory tests were normal in most cases. Five of
47 patients (10.6%) showed mild leukopenia and 2 of them (4.2%) had in-
creased white cell counts. The lowest and the highest leukocyte counts were
2,800/mm3 and 10,000/mm.3 Three patients (6.4%) suffered from thrombocy-
topenia. The lowest thrombocyte count was 100,000/mm3. One patient showed
anemia (Hb: 11 gr/dL), and anemia and thrombocytopenia were observed in
one case. Nine patients (19%) had elevated erythrocyte sedimentation rates.
C-reactiue protein was mildly elevated in 38% of cases (18 of 47). Eight of
the 51 patients (16%) had an elevated ASAT and ALAT level (less than twice
the upper limit of the normal values). In all these cases the laboratory tests
performed 1 month later gave normal results.
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All patients were treated with antibiotics. Doxycycline (100 mg/b.i.d. 14
days) was administered to 79% of patients. Ten were treated with azithromycin
(10 mg/kg q.d. 5 days) and one child with josamycin (500 mg/b.i.d. 14 days).
The treatment was changed in only one patient (doxycycline was substituted
by azithromycin) on account of the development of nausea and diarrhea. In all
cases learning of the signs and symptoms was observed. Evolution of disease
was only available for 34 patients studied prospectively. Fever disappeared
48 h after the beginning of the treatment, and the painful lymphadenopathy
remitted in 1 week for most patients. However, the evolution of the erythema
and the eschar was slower, persisting both for 1 or 2 months. Sixty-six percent
of patients fully recovered. The remaining ones developed persistent alopecia
at the site of the tick bite (0.5–2 cm in diameter).
Serological Tests
IgG antibodies against R. conorii and R. slovaca were tested (IFA) in 31
patients. Evidence of recent infection by a Rickettsia SFG was observed in
19 patients (61%). In 18 of them (95%) seroconversion was detected. In one
out of 19 patients (5%) we observed a fourfold increase in IgG antibodies. In
27 cases (87%) seroconversion or increase of the previous titers was detected
during the first month. Four patients (13%) showed seroconversion in the third
month.
PCR Assays
All EDTA blood samples and skin biopsies were PCR-negative. In 9 of 31
sera tested (29%) ompA PCRs were positive. Sequencing of PCR products was
achieved in only one case. Comparison of the sequence with those deposited
in Genbank revealed 98% identity with a fragment of ompA gene of Rickettsia
sp. strains RpA4, DnS14, and DnS28.
None of the 14 D. marginatus ticks removed from people was infected
with A. phagocytophilum, B. burgdorferi, and F. tularensis. All of them were
infected by SFG Rickettsia. By sequencing procedure (ompA gene) R. slovaca
(100% similarity) was identified in 8 of 10 D. marginatus ticks removed from
patients. Rickettsia sp. strains RpA4, DnS14, and DnS28 (98% similarity) were
identified in the two remaining ones, as well as in all D. marginatus removed
from asymptomatic person.
DISCUSSION
This study describes the epidemiological, clinical, and laboratory findings
for a new TBD in Spain. We first named the syndrome as Dermacentor-borne
necrosis erythema lymphadenopathy (DEBONEL) because D. marginatus is
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the vector implicated in its transmission, and necrosis, erythema, and lym-
phadenopathy are the main clinical findings.4,7
All patients reported in this study were living in La Rioja, where LB and
MSF are endemic.2 To estimate the specificity of epidemiological and clinical
data of DEBONEL, we have also studied prospectively all patients diagnosed
with erythema migrans (early located LB) and MSF at our hospital during
2003–2004. During this period, 27 cases of LB, 24 cases of DEBONEL, and
7 cases of MSF were diagnosed. Therefore, DEBONEL was a prevalent TBD
in La Rioja during this period (21% of cases).
The seasonal distribution of DEBONEL was significantly different (P <
0.05) from that in LB and MSF. DEBONEL occurred mainly during the colder
months, whereas LB was diagnosed from late spring to early autumn, and MSF
in summer. In addition, DEBONEL had a different geographical location. All
cases were located in La Rioja Baja, in areas with low mountains (Wooded
with Holm oaks) and with dry Indo-Mediterranean climate conditions.
In our study females were more frequently involved than males (female/male
ratio: 1.45). On the contrary, LB and MSF were more frequent in males (fe-
male/male ratio: 0.5 and 0.16, respectively) (P < 0.05). The patients’ me-
dian age was 37 years. Nine patients (16.6%) were children younger than
10 years. The average age of DEBONEL patients was significantly younger
(P < 0.05) than the average age of LB (48 years) and MSF patients (55 years).
In different Spanish studies, LB and MSF were also more frequent in males
and their average age was higher.8–11 The site of the tick bite in DEBONEL
was different from that LB and MSF: Patients diagnosed with DEBONEL
were usually bitten on the scalp region (90%), and always on the upper por-
tions the body. However, the tick’s attachment in LB and MSF can appear
on any part on the body with predominance of the lower extremities12 (P
< 0.05). These epidemiological differences between the three TBDs may be
explained by the differences in the characteristics and behaviors of the tick
vector.
Adult D. marginatus ticks’ greatest activity, in La Rioja, is observed from
early autumn to winter,13 which may explain why DEBONEL is more frequent
during the colder months. The geographical distribution of the disease corre-
sponds to the area of D. marginatus distribution in La Rioja.13 On the other
hand, this species seems to prefer to live on hairy animals. To get a host, it
waits higher than other genera (A. Estrada, personal communication). These
facts could explain why children and females are more frequently involved
than males, why the tick bite is usually located on the scalp region, and the fact
that bites outside the head are observed only in males, on hairy regions (arms,
axillas, and thorax).
The clinical symptoms of DEBONEL are different from those of LB and
MSF. Nevertheless, some clinical features are similar in the three TBDs. Ery-
thema migrans (the hallmark of the early located LB) later expands, central
clearing occurs frequently, and it has a big size and does not have a central
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necrosis. However, erythema of DEBONEL is usually small (only 15% were
higher than 5 cm) and always has a central necrosis. General symptoms are rare
and mild in both TBDs, except for headache, which is common in DEBONEL.
Erythema and eschar at the inoculation site were significantly less common
in patients with MSF than in patients with DEBONEL (P < 0.05). In addi-
tion, in MSF patients the eschar fully recovered and its size was smaller. On
the contrary, some patients with DEBONEL, after healing of the eschar, de-
veloped a local alopecia. Regional lymphadenopathy was found less often in
MSF than in DEBONEL (P < 0.05). The presence of fever and rash was also
significantly less common in patients with DEBONEL than in patients with
MSF (P < 0.05). MSF is usually a mild illness, but malignant forms have been
reported in 5–12% of cases associated with 2.5% mortality.10,11 In this new
TBD signs and symptoms were mild in all cases and we have not observed a
fatal evolution in any case.
Similar epidemiological and clinical cases have been reported in France and
Hungary by Raoult and Lakos.14–17 In Hungary the syndrome is known as
tick-borne lymphadenopathy (TIBOLA).
In 1997 R. slovaca was identified by PCR in a skin biopsy from a French pa-
tient with similar clinical manifestations than those seen in La Rioja.14 In 2003
R. slovaca was isolated from a skin biopsy, which demonstrates its implications
in the etiology of the disease.18
In the present study we have attempted to identify the causative agent of this
new TBD in La Rioja. Culture was attempted from 2 skin biopsies, in serum
and blood collected on heparin samples, and from a PCR-positive tick removed
from a patient in other laboratories (Centro de Estudos de Vectores e Doenc¸as
Infecciosas do Instituto Nacional de Sau´de, Portugal and Unite´ des Rickettsies,
Marsella, France) without success. Nevertheless, we have confirmed the SFG
rickettsial infection by PCR in 29% of sera tested, and in all ticks (10) re-
moved from patients. By means of a sequencing procedure R. slovaca (100%
similarity) was identified in 8 of 10 D. marginatus ticks removed from pa-
tients. Rickettsia sp. strains RpA4, DnS14, and DnS28 (98% similarity) were
identified in the two remaining ones, as well as in a serum sample from a
patient.
Rickettsia sp. strains RpA4, DnS14, and DnS28 are closely related and
branched with members of the R. massiliae group. These strains were first
identified in Dermacentor sp. ticks collected in territories of the former Soviet
Union.19,20 The prevalence of Rickettsia sp. strains RpA4, DnS14, and DnS28
in D. marginatus collected from people and from several animal hosts in La Ri-
oja is high (59.3%). Six of 14 (43%) D. marginatus ticks removed from people
were infected by these strains. Moreover only 2 of 6 people (33%) developed
disease. The remaining ones (4/6) did not develop any clinical manifestation.
The pathogenicity of Rickettsia sp. strains RpA4, DnS14, and DnS28 is still
unknown and, up to date, these genotypes have not been implicated in human
disease.
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Our data suggest that R. slovaca is the main etiological agent of DEBONEL
in La Rioja. Nevertheless, it is possible that other Rickettsia sp., such as strains
RpA4, DnS14, and DnS28 may also be implicated in the etiology.
On the other hand, according to our results, DEBONEL may be a prevalent
TBD in Spain and should be suspected following a tick bite. In addition, persons
bitten by D. marginatus infected with R. slovaca had a higher risk of developing
DEBONEL than did those bitten by D. marginatus infected with Rickettsia sp.
strains RpA4, DnS14, and DnS28 (100% and 33%, respectively).
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